Tapering Off GLP-1s: What the Discontinuation Protocols Actually Look Like
Discontinuing a GLP-1 — whether by choice, cost, or medical necessity — isn't a simple stop. Here's what a structured discontinuation protocol actually looks like clinically.
Why discontinuation needs a plan
Stopping a GLP-1 abruptly at a higher dose can bring a faster return of appetite and GI symptom rebound than a gradual taper. There's no universal required tapering protocol, but many clinicians favor a step-down approach over an abrupt stop, particularly for patients who've been on higher maintenance doses for extended periods.
What a typical tapering approach involves
- Gradual dose reduction over several weeks to months rather than immediate cessation, especially from higher doses
- Continued monitoring during the taper period for symptom changes
- A plan for managing appetite and weight regain risk during and after the taper, since this is a well-documented pattern without ongoing intervention
Embody GLP1 From $149
Ongoing clinical guidance that can support a structured tapering plan if you're discontinuing treatment.
Visit Embody GLP1 →Paid linkSesame Care From $29
Licensed physicians who can discuss discontinuation planning specific to your situation.
What patients should know
If you're considering stopping, that's a conversation to have with your prescriber before you stop — not an update you deliver after the fact. A planned taper with a clear rationale for weight-management expectations afterward gives you a meaningfully better outcome than stopping on your own.